Xcept Tablet 10mg

About Xcept Tablet 10mg

Xcept Tablet Uses

• Prevention and treatment of deep venous thrombosis following major orthopedic surgery.
• Treatment of pulmonary embolism and reduction of recurrence risk.
• Stroke prevention in patients with nonvalvular atrial fibrillation.
• Acute coronary syndrome management to reduce cardiovascular events.
• Peripheral artery disease treatment and thrombotic event prevention.

Xcept Tablet Benefits

• Direct factor Xa inhibition provides rapid and predictable anticoagulation.
• Oral administration eliminates need for injections or frequent monitoring.
• Wide therapeutic window reduces need for INR monitoring.
• Lower bleeding risk compared to warfarin in many clinical settings.
• Consistent pharmacokinetics enable predictable dosing.

What Experts Say

Rivaroxaban is a highly selective oral factor Xa inhibitor that directly binds to the active site of factor Xa. This inhibition blocks the amplification phase of the coagulation cascade preventing the conversion of prothrombin to thrombin. By interrupting this critical step, rivaroxaban prevents the formation of fibrin clots essential for thrombus development. Unlike warfarin, rivaroxaban does not require antithrombin as a cofactor enabling independent anticoagulant effects. The drug demonstrates activity against both free and prothrombinase-bound factor Xa providing comprehensive anticoagulation.

Pharmacokinetically, rivaroxaban demonstrates rapid oral absorption with peak plasma concentrations within 2 to 4 hours. The drug is approximately 92 to 95 percent protein-bound. Rivaroxaban undergoes hepatic and renal metabolism with approximately 66 percent eliminated via renal pathways. The elimination half-life approximates 5 to 9 hours in young adults and 11 to 13 hours in elderly patients enabling once or twice-daily dosing. Steady-state concentrations are reached within 2 to 3 days of consistent dosing. Food intake enhances absorption making administration with food advisable.

Clinical efficacy studies demonstrate rivaroxaban is non-inferior to conventional anticoagulants in preventing venous thromboembolism and reducing stroke risk in atrial fibrillation. The EINSTEIN trials showed rivaroxaban efficacy in DVT and PE treatment comparable to warfarin. The ROCKET-AF trial demonstrated stroke prevention superiority in atrial fibrillation. Acute coronary syndrome trials showed additional cardiovascular event reduction. Long-term safety is well-established with bleeding rates comparable to or lower than warfarin.

Drug Class

• Direct Factor Xa Inhibitor, Anticoagulant

Packaging and Quantity

• Blister strip containing 10, 14, or 28 tablets of 2.5 mg, 10 mg, 15 mg, or 20 mg each.

When Not to Use Xcept

• Known hypersensitivity to rivaroxaban or any component of the tablet.
• Active pathological bleeding.
• Severe hepatic impairment.
• Severe renal impairment with creatinine clearance below 15 ml per minute.
• Concurrent use with strong CYP3A4 and P-glycoprotein inhibitors.

Xcept Tablet 10mg formula

• Rivaroxaban

Available forms

• Tablets

How to use Xcept Tablet 10mg?

• Take orally with a full glass of water as directed by your healthcare provider.
• Take with food to enhance absorption.
• Typical dosing is 10 to 20 mg once daily depending on indication.
• For acute DVT or PE treatment: initial dose 15 mg twice daily for 21 days, then 20 mg once daily.
• Take at the same time each day to maintain consistent anticoagulation.
• Do not skip doses without medical guidance.

Drug Interactions

Xcept may interact with various medications affecting efficacy or safety:

• Strong CYP3A4 inhibitors: Ketoconazole, ritonavir, and similar drugs increase rivaroxaban levels; concurrent use contraindicated.
• Antiplatelet agents: Aspirin, clopidogrel, and NSAIDs increase bleeding risk; use with caution.
• Other anticoagulants: Concurrent use with warfarin or other anticoagulants increases bleeding risk.
• NSAIDs: Increase gastrointestinal bleeding risk and reduce renal function.

Risks and warnings

• Bleeding risk: Rivaroxaban increases bleeding risk; report any signs of bleeding immediately.
• Spinal anesthesia: Epidural or spinal anesthesia carries spinal hematoma risk; coordinate timing with physician.
• Renal impairment: Dose adjustment required in moderate to severe renal disease.
• Hepatic disease: Contraindicated in severe liver disease; use with caution in mild to moderate disease.
• Pregnancy: Contraindicated throughout pregnancy due to fetal bleeding risk.
• Breastfeeding: Rivaroxaban is not recommended during breastfeeding.
• Drug interactions: Strong CYP3A4 inhibitors contraindicated; antiplatelet drugs increase bleeding risk.

Xcept Tablet Side Effects

Following are commonly reported adverse effects:

• Bleeding or bruising.
• Nosebleeds or gum bleeding.
• Headache.
• Dizziness.
• Gastrointestinal upset, nausea, or constipation.

Serious side effects requiring immediate medical attention:

• Severe bleeding or hemorrhage.
• Signs of stroke or TIA.
• Spinal hematoma with neurological symptoms.
• Severe allergic reaction.

Storage Conditions

• Store at room temperature below 30 degrees Celsius.
• Protect from light and moisture.
• Keep in original blister packaging.
• Do not store in bathroom or areas with high humidity.
• Keep out of reach of children and pets.
• Do not use after the expiration date on the packaging.